Abstract:With the exponential progress in the field of cheminformatics, the conventional modeling approaches have so far been to employ supervised and unsupervised machine learning (ML) and deep learning models, utilizing the standard molecular descriptors, which represent the structural, physicochemical, and electronic properties of a particular compound. Deviating from the conventional approach, in this investigation, we have employed the classification Read-Across Structure-Activity Relationship (c-RASAR), which involves the amalgamation of the concepts of classification-based quantitative structure-activity relationship (QSAR) and Read-Across to incorporate Read-Across-derived similarity and error-based descriptors into a statistical and machine learning modeling framework. ML models developed from these RASAR descriptors use similarity-based information from the close source neighbors of a particular query compound. We have employed different classification modeling algorithms on the selected QSAR and RASAR descriptors to develop predictive models for efficient prediction of query compounds' hepatotoxicity. The predictivity of each of these models was evaluated on a large number of test set compounds. The best-performing model was also used to screen a true external data set. The concepts of explainable AI (XAI) coupled with Read-Across were used to interpret the contributions of the RASAR descriptors in the best c-RASAR model and to explain the chemical diversity in the dataset. The application of various unsupervised dimensionality reduction techniques like t-SNE and UMAP and the supervised ARKA framework showed the usefulness of the RASAR descriptors over the selected QSAR descriptors in their ability to group similar compounds, enhancing the modelability of the dataset and efficiently identifying activity cliffs. Furthermore, the activity cliffs were also identified from Read-Across by observing the nature of compounds constituting the nearest neighbors for a particular query compound. On comparing our simple linear c-RASAR model with the previously reported models developed using the same dataset derived from the US FDA Orange Book ( https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm ), it was observed that our model is simple, reproducible, transferable, and highly predictive. The performance of the LDA c-RASAR model on the true external set supersedes that of the previously reported work. Therefore, the present simple LDA c-RASAR model can efficiently be used to predict the hepatotoxicity of query chemicals.

Bayesian joint modeling of chemical structure and dose response curves

Bayesian Dose Finding by Jointly Modelling Toxicity and Efficacy As Time-To-Event Outcomes

Bayesian Dose Finding for Combined Drugs with Discrete and Continuous Doses

Bayesian Matrix Completion for Hypothesis Testing

Reflected generalized concentration addition and Bayesian hierarchical models to improve chemical mixture prediction

Inferring Synergistic and Antagonistic Interactions in Mixtures of Exposures

Phase I Trial Design for Drug Combinations with Bayesian Model Averaging.

A Bayesian dose-response meta-analysis model: simulation study and application

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Bayesian hybrid dose-finding design in phase I oncology clinical trials.

Toxicity profiling of engineered nanomaterials via multivariate dose-response surface modeling

Performance of variable and function selection methods for estimating the non-linear health effects of correlated chemical mixtures: a simulation study

Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose-Response Uncertainty

Bayesian prediction for physical models with application to the optimization of the synthesis of pharmaceutical products using chemical kinetics

Modeling Biphasic, Non-Sigmoidal Dose-Response Relationships: Comparison of Brain-Cousens and Cedergreen Models for a Biochemical Dataset

A New Bayesian Dose-Finding Design for Drug Combination Trials

Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling

Principled Drug-Drug Interaction Terms for Bayesian Logistic Regression Models of Drug Safety in Oncology Phase I Combination Trials

The application of chemical similarity measures in an unconventional modeling framework c-RASAR along with dimensionality reduction techniques to a representative hepatotoxicity dataset

Predictive Models for Human Organ Toxicity Based on in Vitro Bioactivity Data and Chemical Structure

Bayesian Nonparametric Risk Assessment in Developmental Toxicity Studies with Ordinal Responses